Quantum Biopharma (NASDAQ:QNTM) Issues Quarterly Earnings Results, Misses Estimates By $2.09 EPS

Quantum Biopharma (NASDAQ:QNTM) released its earnings results on Friday. The company reported ($2.89) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($0.80) by ($2.09), Zacks reports.

Quantum Biopharma Price Performance

NASDAQ:QNTM opened at $8.56 on Friday. The firm has a market cap of $16.43 million, a PE ratio of -0.56 and a beta of 0.37. The firm has a 50 day simple moving average of $6.20 and a 200-day simple moving average of $5.05. Quantum Biopharma has a 1-year low of $2.70 and a 1-year high of $18.00.

Quantum Biopharma Company Profile

Quantum Biopharma Ltd. is a biotechnology pharmaceutical research and development company, which focuses on the cultivation, process, and sale of medical cannabis. It operates through the Biotechnology and Strategic Investments segments. The Biotechnology segment is involved in the research and development of the company’s three drug candidates consisting of FSD-PEA, Lucid-PSYCH, and Lucid-MS.